InspireMD (NSPR) Net Income Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56.35% |
| Sep 30, 2025 | -42.84% |
| Jun 30, 2025 | -39.32% |
| Mar 31, 2025 | -41.49% |
| Dec 31, 2024 | 54.77% |
| Sep 30, 2024 | -32.53% |
| Jun 30, 2024 | -30.22% |
| Mar 31, 2024 | -18.25% |
| Dec 31, 2023 | -21.29% |
| Sep 30, 2023 | -22.90% |
| Jun 30, 2023 | -53.34% |
| Mar 31, 2023 | -12.89% |
| Dec 31, 2022 | -26.30% |
| Sep 30, 2022 | -16.77% |
| Jun 30, 2022 | -15.11% |
| Mar 31, 2022 | -11.86% |
| Dec 31, 2021 | -12.31% |
| Sep 30, 2021 | -15.33% |
| Jun 30, 2021 | -12.50% |
| Mar 31, 2021 | -7.57% |
| Dec 31, 2020 | -5.43% |
| Sep 30, 2020 | 9.63% |
| Jun 30, 2020 | 8.55% |
| Mar 31, 2019 | 11.68% |
| Sep 30, 2018 | 12.61% |
| Jun 30, 2018 | 46.97% |
| Mar 31, 2018 | 13.33% |
| Dec 31, 2017 | 4.83% |
| Sep 30, 2017 | 22.59% |
| Mar 31, 2017 | 4.01% |
| Dec 31, 2016 | 22.73% |
| Sep 30, 2016 | 2.66% |
| Jun 30, 2016 | 2.90% |
| Mar 31, 2016 | -3.51% |
| Dec 31, 2015 | -19.30% |
| Sep 30, 2015 | -33.87% |
| Jun 30, 2015 | -42.37% |